Elad Zisman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Elad Zisman

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Current Neurology and Neuroscience Reports|August 24, 2019

MYORG Mutations: a Major Cause of Recessive Primary Familial Brain CalcificationMax Bauer, Dolev Rahat, Elad Zisman, et al.

Frontiers in Immunology|January 23, 2025

Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapyShay Tzaban, Ori Stern, Elad Zisman, et al.

Cancer Immunology Research|March 25, 2021

Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector FunctionsEmma Hajaj, Elad Zisman, Shay Tzaban, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Current Neurology and Neuroscience Reports|August 24, 2019

MYORG Mutations: a Major Cause of Recessive Primary Familial Brain CalcificationMax Bauer, Dolev Rahat, Elad Zisman, et al.

Frontiers in Immunology|January 23, 2025

Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapyShay Tzaban, Ori Stern, Elad Zisman, et al.

Cancer Immunology Research|March 25, 2021

Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector FunctionsEmma Hajaj, Elad Zisman, Shay Tzaban, et al.

Pageof 1